P-075 Neoadjuvant chemotherapy of esophageal cancer

neoadjuvant chemotherapy in esophageal cancer: single institution experience

background : esophageal cancer is a major clinical problem that has a generally poor prognosis. as a result, there has been interest in combining surgery with neoadjuvant chemotherapy in an attempt to improve clinical outcomes. evidence for clinical benefit from preoperative chemotherapy exists but it is not clear which patients (stage, tumor location, and histology) will benefit the most from ...

Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer.

BACKGROUND A phase II trial to evaluate neoadjuvant (NAD), surgery and adjuvant (AD) combination chemotherapy without radiation therapy (RT) for patients with esophageal adenocarcinoma staged with endoscopic ultrasound and CT as T3N1 was carried out. METHODS Thirty-three eligible patients were enrolled. NAD therapy was administered in two 49-day cycles and included cisplatin, floxuridine, pac...

The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery

Introduction: Early diagnosis and appropriate treatment is required in esophageal cancer due to its invasive nature. The aim of this study was to evaluate early post-esophagectomy complications in patients with esophageal cancer who received neoadjuvant chemoradiotherapy (NACR).   Materials and Methods: This randomized clinical trial was carried out between 2009 and 2011. Patients with lower-th...

Neoadjuvant chemotherapy in bladder cancer

The use of neoadjuvant chemotherapy is an important element in the management of advanced bladder cancer. While definitive surgical management of locally advanced disease remains the gold standard of treatment, evidence over the years has repeatedly and consistently demonstrated the survival benefits of presurgical systemic chemotherapy. Incorporation of neoadjuvant chemotherapy into the treatm...

Neoadjuvant Chemotherapy for Breast Cancer